Home > Insider Trading > Filing (0001209191-19-054530)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1783183	Phathom Pharmaceuticals Inc.	PHAT	Pharmaceutical Preparations (2834)	824151574

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1791944	S. Jonathan Edwards	C/O Phathom Pharmaceuticals, Inc. 2150 E. Lake Cook Road, Suite 800 Buffalo Grove IL 60089		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-10-29	991,672	$15.20	991,672	No	4	C	Indirect	By Medicxi Growth I LP
Common Stock	Acquisiton	2019-10-29	23,558	$15.20	23,558	No	4	C	Indirect	By Medicxi Growth Co-Invest I LP
Common Stock	Acquisiton	2019-10-29	1,028,205	$19.00	2,019,877	No	4	P	Indirect	By Medicxi Growth I LP
Common Stock	Acquisiton	2019-10-29	24,426	$19.00	47,984	No	4	P	Indirect	By Medicxi Growth Co-Invest I LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Medicxi Growth I LP
No	4	C	Indirect	By Medicxi Growth Co-Invest I LP
No	4	P	Indirect	By Medicxi Growth I LP
No	4	P	Indirect	By Medicxi Growth Co-Invest I LP

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Convertible Promissory Notes	Disposition	2019-10-29	0	$0.00	991,672	$15.20
Common Stock	Convertible Promissory Notes	Disposition	2019-10-29	0	$0.00	23,558	$15.20

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2020-05-07	No	4	C	Indirect
0		2020-05-07	No	4	C	Indirect

Footnotes

Immediately prior to the closing of the Issuer's initial public offering, the outstanding principal and unpaid accrued interest due on the Convertible Promissory Notes automatically converted into shares of the Issuer's Common Stock.
Held by Medicxi Growth I LP ("Medicxi Growth I"). Medicxi Growth I GP Limited ("Medicxi Growth I GP") is the sole general partner of Medicxi Growth I, and Medicxi Ventures Management (Jersey) Limited ("Medicxi Manager") is the manager of Medicxi Growth I and Medicxi Growth Co-Invest I LP ("Medicxi Growth Co-Invest I"). The Reporting Person is a partner of an affiliate of Medicxi Manager. The Reporting Person disclaims Section 16 beneficial ownership of the securities held by Medicxi Growth I, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
Held by Medicxi Growth Co-Invest I. The Reporting Person disclaims Section 16 beneficial ownership of the securities held by Medicxi Growth Co-Invest I, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.